Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

712 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trial.
Dijkstra EA, Zwart WH, Nilsson PJ, Putter H, Roodvoets AGH, Meershoek-Klein Kranenbarg E, Frödin JE, Nygren P, Østergaard L, Kersten C, Verbiené I, Cervantes A, Hendriks MP, Capdevila J, Edhemovic I, van de Velde CJH, Marijnen CAM, van Etten B, Hospers GAP, Glimelius B; collaborative investigators. Dijkstra EA, et al. Among authors: van etten b, van de velde cjh. ESMO Open. 2023 Apr;8(2):101158. doi: 10.1016/j.esmoop.2023.101158. Epub 2023 Mar 3. ESMO Open. 2023. PMID: 36871393 Free PMC article. Clinical Trial.
Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not.
Zwart WH, Dijkstra EA, Putter H, Marijnen CAM, Nilsson PJ, van de Velde CJH, van Etten B, Hospers GAP, Glimelius B. Zwart WH, et al. Among authors: van etten b, van de velde cjh. ESMO Open. 2023 Oct;8(5):101645. doi: 10.1016/j.esmoop.2023.101645. Epub 2023 Sep 14. ESMO Open. 2023. PMID: 37713932 Free PMC article. No abstract available.
Corrigendum to "Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not": [ESMO Open 8 (2023) 101645].
Zwart WH, Dijkstra EA, Putter H, Marijnen CAM, Nilsson PJ, van de Velde CJH, van Etten B, Hospers GAP, Glimelius B. Zwart WH, et al. Among authors: van etten b, van de velde cjh. ESMO Open. 2023 Dec;8(6):102042. doi: 10.1016/j.esmoop.2023.102042. Epub 2023 Oct 20. ESMO Open. 2023. PMID: 37866027 Free PMC article. No abstract available.
Effect of preoperative chemotherapy on the histopathological classification of gastric cancer.
Caspers IA, Biesma HD, Wiklund K, Pontén F, Lind P, Nordsmark M, Sikorska K, Meershoek-KleinKranenbarg E, Hartgrink HH, van de Velde CJH, van Sandick JW, Verheij M, Cats A, van Grieken NCT. Caspers IA, et al. Among authors: van de velde cjh. Gastric Cancer. 2024 Jan;27(1):102-109. doi: 10.1007/s10120-023-01442-w. Epub 2023 Nov 10. Gastric Cancer. 2024. PMID: 37947918 Free PMC article.
Surgical Outcomes after Radiotherapy in Rectal Cancer.
Temmink SJD, Peeters KCMJ, Nilsson PJ, Martling A, van de Velde CJH. Temmink SJD, et al. Among authors: van de velde cjh. Cancers (Basel). 2024 Apr 18;16(8):1539. doi: 10.3390/cancers16081539. Cancers (Basel). 2024. PMID: 38672621 Free PMC article. Review.
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial.
Zwart WH, Temmink SJD, Hospers GAP, Marijnen CAM, Putter H, Nagtegaal ID, Blomqvist L, Kranenbarg EM, Roodvoets AGH, Martling A, van de Velde CJH, Glimelius B, Peeters KCMJ, van Etten B, Nilsson PJ; Collaborative investigators. Zwart WH, et al. Among authors: van de velde cjh. Eur J Cancer. 2024 Jun;204:114044. doi: 10.1016/j.ejca.2024.114044. Epub 2024 Apr 7. Eur J Cancer. 2024. PMID: 38636289 Free article. Clinical Trial.
Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM Trial.
Bartlett JMS, Xu K, Wong J, Pond G, Zhang Y, Spears M, Salunga R, Mallon E, Taylor KJ, Hasenburg A, Markopoulos C, Dirix L, van de Velde CJH, Rea D, Schnabel CA, Treuner K, Bayani J. Bartlett JMS, et al. Among authors: van de velde cjh. Clin Cancer Res. 2024 Apr 15;30(8):1509-1517. doi: 10.1158/1078-0432.CCR-23-2436. Clin Cancer Res. 2024. PMID: 38345755 Free PMC article.
Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer.
Ozturk SK, Martinez CG, Mens D, Verhoef C, Tosetto M, Sheahan K, de Wilt JHW, Hospers GAP, van de Velde CJH, Marijnen CAM, van der Post RS, Nagtegaal ID. Ozturk SK, et al. Among authors: van de velde cjh. Histopathology. 2024 May;84(6):935-946. doi: 10.1111/his.15134. Epub 2024 Jan 8. Histopathology. 2024. PMID: 38192084
Abandonment of Routine Radiotherapy for Nonlocally Advanced Rectal Cancer and Oncological Outcomes.
Hazen SJA, Sluckin TC, Intven MPW, Beets GL, Beets-Tan RGH, Borstlap WAA, Buffart TE, Buijsen J, Burger JWA, van Dieren S, Furnée EJB, Geijsen ED, Hompes R, Horsthuis K, Leijtens JWA, Maas M, Melenhorst J, Nederend J, Peeters KCMJ, Rozema T, Tuynman JB, Verhoef C, de Vries M, van Westreenen HL, de Wilt JHW, Zimmerman DDE, Marijnen CAM, Tanis PJ, Kusters M; Dutch Snapshot Research Group. Hazen SJA, et al. JAMA Oncol. 2024 Feb 1;10(2):202-211. doi: 10.1001/jamaoncol.2023.5444. JAMA Oncol. 2024. PMID: 38127337
712 results